Drug Shortage Report for TESTOSTERONE ENANTHATE INJECTION, USP
Report ID | 238542 |
Drug Identification Number | 02536315 |
Brand name | TESTOSTERONE ENANTHATE INJECTION, USP |
Common or Proper name | TESTOSTERONE ENANTHATE INJECTION, USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE ENANTHATE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 5mL |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-10-11 |
Actual start date | |
Estimated end date | 2024-12-10 |
Actual end date | 2024-12-12 |
Shortage status | Resolved |
Updated date | 2024-12-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-12-13 | French | Compare |
v6 | 2024-12-13 | English | Compare |
v5 | 2024-11-28 | French | Compare |
v4 | 2024-11-28 | English | Compare |
v3 | 2024-10-12 | English | Compare |
v2 | 2024-09-26 | French | Compare |
v1 | 2024-09-26 | English | Compare |
Showing 1 to 7 of 7